Stock Comparison
ARWR vs VRTX
Arrowhead Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.11B
$124.70B
P/E (TTM)
—
29.2
Forward P/E
111.1
25.8
Price/Sales
17.9
10.2
Price/Book
18.2
6.4
EV/EBITDA
27.9
24.0
Dividend Yield
—
—
Profitability
Net Margin
-48.40%
35.50%
Operating Margin
-191.60%
38.10%
Return on Equity
-42.40%
24.20%
Return on Assets
-7.22%
12.10%
Growth (YoY)
Revenue Growth
-86.40%
7.80%
Earnings Growth
9.80%
61.40%
Price & Risk
Beta
1.3
0.3
52-Week High
$84.55
$507.92
52-Week Low
$14.30
$362.50
Analyst Target
$89.08
$548.69
Compare ARWR and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.